Overview
2. Optic nerve imaging (mainly optical coherence tomography)
3. Idiopathic intracranial hypertension
4. Optic neuritis
Current Appointments & Affiliations
Professor of Ophthalmology
·
2025 - Present
Ophthalmology, Neuro-Ophthalmology,
Ophthalmology
Recent Publications
Evaluating the Role of Virtual Reality Visual Fields (VRF) in the Diagnosis and Management of Pediatric Neuro-Ophthalmic Conditions.
Journal Article Am J Ophthalmol · January 2026 OBJECTIVE: Virtual reality field testing (VRF) is feasible and reliable in adults and in children with normal and glaucomatous eyes, but its role in pediatric neuro-ophthalmic conditions remains unexplored. PURPOSE: To evaluate the feasibility of using VRF ... Full text Link to item CiteVirtual reality field testing in children with normal eyes and glaucoma: comparison of game-based versus Humphrey visual field-equivalent algorithms.
Journal Article J AAPOS · December 2025 BACKGROUND: Virtual reality-based field (VRF) perimetry presents an alternative to standard automated perimetry, offering both game-based and Humphrey-equivalent algorithms. Comparative performance of these two algorithms is not well-documented. We evaluat ... Full text Link to item CiteGalloway-Mowat syndrome with retinal involvement associated with a novel WDR73 variant: case report and review of the literature.
Journal Article Ophthalmic Genet · February 2025 INTRODUCTION: Galloway-Mowat syndrome (GAMOS) is a rare autosomal recessive disorder classically characterized by central nervous system and renal abnormalities. Optic atrophy has been reported as a common ophthalmic feature, and other characteristics, inc ... Full text Link to item CiteRecent Grants
A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with chronic thyroid eye disease (TED)
Clinical TrialPrincipal Investigator · Awarded by Viridian Therapeutics · 2025 - 2030A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with active thyroid eye disease (TED)
Clinical TrialPrincipal Investigator · Awarded by Viridian Therapeutics · 2025 - 2030PROSPECTIVE PEDIATRIC PSEUDOTUMOR CEREBRI SYNDROME STUDY (PPTS)
ResearchPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2024 - 2026View All Grants
Education, Training & Certifications
American University of Beirut (Lebanon) ·
2001
M.D.